Pembrolizumab monotherapy shows promise for untreated advanced HCC in phase 2May 17, 2022Hepatocellular Carcinoma
Early-stage HCC: OLT offers better survival outcomes than ablative therapies in the elderlyMay 17, 2022Hepatocellular Carcinoma
IBD after age 60: More evidence antibiotics play a roleMay 17, 2022Mixed TopicsIBD & Intestinal Disorders
TNF blockers beat newer biologics in Crohn’s disease: Meta-analysisMay 12, 2022IBD & Intestinal Disorders
AGA Clinical Practice Update: Expert review of dietary options for IBSMay 12, 2022IBD & Intestinal Disorders
